Rapid Diagnostics ML Limited have developed a saliva sample Real-Time PCR Point of Care test for the accurate detection of COVID-19. “In the last few weeks we have succeeded in developing a new saliva sample Covid-19 test. This is a great alternative to the invasive, and sometimes painful, deep nasal (mucus) sample and throat (sputum)...
Category: News
adminPost
Rapid Diagnostics Resurrects Multiplex MiniLab Platform, Targets TB POC Test
LEO O’CONNOR DECEMBER 18, 2019 NEW YORK – After years developing technology to do multiplex testing for infectious diseases, Enigma Diagnostics shuttered about two years ago without much fanfare. But thanks to a former investor in the company, Enigma’s technology may live on. The investor, Robert Clink, had invested a large part of the £140 million...
adminPost
Regulatory Approval
The MiniLab and the Respiratory Assay (ML Influenza A/B RSV test, part ML-CA-0001) received the EC Declaration of Conformity in July 2016
adminPost
American Society for Microbiology
Journal of Clinical Microbiology. January 2016 Volume 54 Number 1
(Available for Download)